284 related articles for article (PubMed ID: 15993365)
1. Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes.
Chavez-Rueda K; Hérnández J; Zenteno E; Leaños-Miranda A; Legorreta-Haquet MV; Blanco-Favela F
Clin Immunol; 2005 Aug; 116(2):182-91. PubMed ID: 15993365
[TBL] [Abstract][Full Text] [Related]
2. Prolactin effect on CD69 and CD154 expression by CD4+ cells from systemic lupus erythematosus patients.
Chavez-Rueda K; Legorreta-Haquet MV; Cervera-Castillo H; Sánchez L; Jara LJ; Zenteno E; Blanco-Favela F
Clin Exp Rheumatol; 2005; 23(6):769-77. PubMed ID: 16396693
[TBL] [Abstract][Full Text] [Related]
3. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis.
De Miguel S; Galocha B; Jover JA; Bañares A; Hernández-García C; García-Asenjo JA; Fernández-Gutiérrez B
J Rheumatol; 2001 Jun; 28(6):1222-8. PubMed ID: 11409113
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulation of autocrine prolactin: suppressing the expression of costimulatory molecules and cytokines in T lymphocytes by prolactin receptor knockdown.
Xu D; Lin L; Lin X; Huang Z; Lei Z
Cell Immunol; 2010; 263(1):71-8. PubMed ID: 20307875
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.
Lisowska KA; Debska-Slizien A; Radzka M; Witkowski JM; Rutkowski B; Bryl E
Artif Organs; 2010 Mar; 34(3):E77-84. PubMed ID: 20447038
[TBL] [Abstract][Full Text] [Related]
7. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids inhibit CD40 ligand expression of peripheral CD4+ lymphocytes.
Bischof F; Melms A
Cell Immunol; 1998 Jul; 187(1):38-44. PubMed ID: 9682002
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
11. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
12. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.
Conti L; Cardone M; Varano B; Puddu P; Belardelli F; Gessani S
Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400
[TBL] [Abstract][Full Text] [Related]
13. Effect of prolactin on lymphocyte activation from systemic lupus erythematosus patients.
Chavez-Rueda K; Legorreta-Haquet VM; Cervera-Castillo H; Sánchez L; Jara LJ; Zenteno E; Chavez-Sanchez L; Blanco-Favela F
Ann N Y Acad Sci; 2007 Jun; 1108():157-65. PubMed ID: 17893982
[TBL] [Abstract][Full Text] [Related]
14. Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
Clark GJ; Rao M; Ju X; Hart DN
J Leukoc Biol; 2007 Nov; 82(5):1126-35. PubMed ID: 17702825
[TBL] [Abstract][Full Text] [Related]
15. Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers.
Borges O; Borchard G; de Sousa A; Junginger HE; Cordeiro-da-Silva A
Int J Pharm; 2007 Jun; 337(1-2):254-64. PubMed ID: 17317051
[TBL] [Abstract][Full Text] [Related]
16. Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues.
Bosè F; Raeli L; Garutti C; Frigerio E; Cozzi A; Crimi M; Caprioli F; Scavelli R; Altomare G; Geginat J; Abrignani S; Reali E
Clin Immunol; 2011 May; 139(2):164-76. PubMed ID: 21334981
[TBL] [Abstract][Full Text] [Related]
17. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
[TBL] [Abstract][Full Text] [Related]
18. Platelets inhibit in vitro response of lymphocytes to mitogens.
Wang Y; Niu J
Immunol Lett; 2008 Aug; 119(1-2):57-61. PubMed ID: 18514331
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
20. Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.
Im Hof M; Williamson L; Summerfield A; Balmer V; Dutoit V; Kandimalla ER; Yu D; Zurbriggen A; Doherr MG; Peel J; Roosje PJ
Vet Immunol Immunopathol; 2008 Jul; 124(1-2):120-31. PubMed ID: 18452997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
